Clinical Trials Logo

Open Fracture of Hip clinical trials

View clinical trials related to Open Fracture of Hip.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT01509118 Recruiting - Clinical trials for Open Fracture of Hip

Rivaroxaban Safety Profile in the Prophylaxis of Venous Thromboembolism After Hip Fracture Surgery

Start date: July 2011
Phase: N/A
Study type: Observational

Arterial and venous thromboembolism represents one of the most common preventable health problems. Patients undergoing surgery, especially hip fracture surgery are at high risk for deep vein thromboembolism (VTE) without thromboprophylaxis. In the absence of prophylaxis, the incidence of fatal pulmonary embolism (PE) after Hip Fracture Surgery (HFS) is reportedly 4%-12%. Provision of thromboprophylaxis to all patients who undergo HFS is recommended.